Technical Analysis for SBPH - Spring Bank Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 11.07 0.73% 0.08
SBPH closed up 0.73 percent on Wednesday, January 16, 2019, on 19 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical SBPH trend table...

Date Alert Name Type % Chg
Jan 16 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jan 16 Narrow Range Bar Range Contraction 0.00%
Jan 16 NR7 Range Contraction 0.00%
Jan 16 Inside Day Range Contraction 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Overbought Stochastic Strength 0.00%
Jan 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.73%
Jan 15 Wide Bands Range Expansion 0.73%
Jan 15 Overbought Stochastic Strength 0.73%
Jan 14 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.21%

Older signals for SBPH ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of a class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its SMNH compounds are small segments of nucleic acids that are design to target and modulate the activity of specific proteins implicated in various disease states. The company's lead product candidate is SB 9200, which completed a Phase 1 clinical trial for the treatment of chronic hepatitis B virus and respiratory syncytial virus. It also develops preclinical product candidates, such as SB 9400, SB 9941 and SB 9946 for RNA viral diseases. The company was formerly known as Spring Bank Technologies, Inc. and changed its name to Spring Bank Pharmaceuticals, Inc. in May 2008. Spring Bank Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Milford, Massachusetts.
Is SBPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.95
52 Week Low 8.14
Average Volume 36,431
200-Day Moving Average 12.4614
50-Day Moving Average 10.698
20-Day Moving Average 10.354
10-Day Moving Average 11.1965
Average True Range 0.778
ADX 16.97
+DI 18.1202
-DI 17.066
Chandelier Exit (Long, 3 ATRs ) 9.566
Chandelier Exit (Short, 3 ATRs ) 10.474000000000001
Upper Bollinger Band 12.4221
Lower Bollinger Band 8.2859
Percent B (%b) 0.67
BandWidth 39.947846
MACD Line 0.2404
MACD Signal Line 0.1127
MACD Histogram 0.1277
Fundamentals Value
Market Cap 140.56 Million
Num Shares 12.7 Million
EPS -2.50
Price-to-Earnings (P/E) Ratio -4.43
Price-to-Sales 0.00
Price-to-Book 4.56
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.51
Resistance 3 (R3) 11.47 11.29 11.43
Resistance 2 (R2) 11.29 11.18 11.31 11.41
Resistance 1 (R1) 11.18 11.11 11.24 11.22 11.38
Pivot Point 11.00 11.00 11.03 11.02 11.00
Support 1 (S1) 10.89 10.89 10.95 10.93 10.76
Support 2 (S2) 10.71 10.82 10.73 10.73
Support 3 (S3) 10.60 10.71 10.71
Support 4 (S4) 10.64